Authors/Disclosures
|
Randolph S. Marshall, MD, FAAN
(Columbia University)
|
The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care. |
|
Kyra O'Brien, MD
(University of Pennsylvania)
|
Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. O'Brien has received research support from Davos Alzheimer's Collaborative. The institution of Dr. O'Brien has received research support from Eli Lilly. The institution of Dr. O'Brien has received research support from AHRQ. The institution of Dr. O'Brien has received research support from NIA. |
|
Sumanjit Kaur, MD
|
No disclosure on file |
|
John W. Krakauer, MD
(Johns Hopkins University)
|
No disclosure on file |
|
|
No disclosure on file |
|
Rafael Rodriguez, MD
(Neurophysiology Center, P.A.)
|
No disclosure on file |
|
|
No disclosure on file |
|
Chilvana V. Patel, MBBS, FAAN
|
Dr. Patel has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Joanne Festa, PhD
(Neurological Institute)
|
No disclosure on file |
|
Xiang Fang, MD, PhD, FAAN
(University of Texas Medical Branch)
|
Dr. Fang has nothing to disclose. |
|
Ronald M. Lazar, PhD, FAHA, FAAN
(University of Alabama At Birmingham)
|
Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care. |